M. Caulfield

发表

Muscarinic receptors--characterization, coupling and function.

M. Caulfield, 1993, Pharmacology & therapeutics.

Genotypic m3‐Muscarinic Receptors Preferentially Inhibit M‐currents in DNA‐transfected NG108‐15 Neuroblastoma × Glioma Hybrid Cells

D. A. Brown, H. Higashida, M. Caulfield, 1991, The European journal of neuroscience.

Inhibition of protein kinase C prevents phorbol ester- but not muscarine-induced depolarizations in the rat superior cervical ganglion

E. Grove, M. Caulfield, F. Evans, 1990, Neuroscience Letters.

Hyperpolarizing 'alpha 2'-adrenoceptors in rat sympathetic ganglia.

D. A. Brown, M. Caulfield, 1979, British journal of pharmacology.

Mediation of nicotine-induced convulsions by central nicotinic receptors of the ‘C6’ type

G. Higgins, M. Caulfield, 1983, Neuropharmacology.

Selective activation of heterologously expressed G protein‐gated K+ channels by M2 muscarinic receptors in rat sympathetic neurones

D. A. Brown, D. Brown, M. Caulfield, 1999, The Journal of physiology.

Activation, cellular redistribution and enhanced degradation of the G proteins Gq and G11 by endogenously expressed and transfected phospholipase C-coupled muscarinic m1 acetylcholine receptors.

G. Milligan, P. Svoboda, M. Caulfield, 1996, Progress in brain research.

Neurotransmitters inhibit the omega-conotoxin-sensitive component of Ca current in neuroblastoma × glioma hybrid (NG108-15) cells, not the nifedipine-sensitive component

D. A. Brown, M. Caulfield, J. Robbins, 1992, Pflügers Archiv.

Muscarinic receptor-mediated inhibition of voltage-activated Ca current in neuroblastoma × glioma hybrid (NG 108-15) cells — reduction of muscarinic agonist and antagonist potency by tetraethylammonium (TEA)

M. Caulfield, 1991, Neuroscience Letters.

Methyl lycaconitine: A novel nicotinic antagonist

D. Bertrand, A. Drasdo, S. Wonnacott, 1992, Molecular and Cellular Neuroscience.

Pharmacology of the putative M4 muscarinic receptor mediating Ca‐current inhibition in neuroblastoma × glioma hybrid (NG 108–15) cells

D. Brown, M. Caulfield, David A. Brown, 1991, British journal of pharmacology.

Selective coupling of different muscarinic acetylcholine receptors to neuronal calcium currents in DNA-transfected cells

K. Fukuda, S. Numa, D. Brown, 1990, Proceedings of the Royal Society of London. Series B: Biological Sciences.

HYPERPOLARIZING ‘α2’‐ADRENOCEPTORS IN RAT SYMPATHETIC GANGLIA

D. Brown, M. Caulfield, David A. Brown, 1979 .

Central administration of the muscarinic receptor subtype ‐ selective antagonist pirenzepine selectively impairs passive avoidance learning in the mouse

G. Higgins, D. Straughan, M. Caulfield, 1983, The Journal of pharmacy and pharmacology.

Cannabinoid receptor agonists inhibit Ca current in NG108–15 neuroblastoma cells via a Pertussis toxin‐sensitive mechanism

D. Brown, M. Caulfield, David A. Brown, 1992, British journal of pharmacology.

POSTSYNAPTIC ACTIONS OF ACETYLCHOLINE - THE COUPLING OF MUSCARINIC RECEPTOR SUBTYPES TO NEURONAL ION CHANNELS

D. A. Brown, H. Higashida, M. Caulfield, 1993 .

The naphthalenesulphonamide calmodulin antagonist W7 and its 5-iodo-1-C8 analogue inhibit potassium and calcium currents in NG108-15 neuroblastoma × glioma cells in a manner possibly unrelated to their antagonism of calmodulin

D. A. Brown, G. Blackburn, M. Caulfield, 1991, Neuroscience Letters.

Use of antisense oligodeoxynucleotides and monospecific antisera to inhibit G-protein gene expression in cultured neurons.

M. Caulfield, N. Buckley, J. ffrench-Mullen, 1995, Biochemical Society transactions.